Pretreatment with 1,8-cineole potentiates thioacetamide-induced hepatotoxicity and immunosuppression

Arch Pharm Res. 2004 Jul;27(7):781-9. doi: 10.1007/BF02980149.

Abstract

The effect of 1,8-cineole on cytochrome P450 (CYP) expression was investigated in male Sprague Dawley rats and female BALB/c mice. When rats were treated orally with 200, 400 and 800 mg/kg of 1,8-cineole for 3 consecutive days, the liver microsomal activities of benzyloxyresorufin- and pentoxyresorufin-omicron-dealkylases and erythromycin N-demethylase were dose-dependently induced. The Western immunoblotting analyses clearly indicated the induction of CYP 2B1/2 and CYP 3A1/2 proteins by 1,8-cineole. At the doses employed, 1,8-cineole did not cause toxicity, including hepatotoxicity. Subsequently, 1,8-cineole was applied to study the role of metabolic activation in thioacetamide-induced hepatotoxicity and/or immunotoxicity in animal models. To investigate a possible role of metabolic activation by CYP enzymes in thioacetamide-induced hepatotoxicity, rats were pre-treated with 800 mg/kg of 1 ,8-cineole for 3 days, followed by a single intraperitoneal treatment with 50 and 100 mg/kg of thioacetamide in saline. 24 h later, thioacetamide-induced hepatotoxicity was significantly potentiated by the pretreatment with 1,8-cineole. When female BALB/c mice were pretreated with 800 mg/kg of 1,8-cineole for 3 days, followed by a single intraperitoneal treatment with 100 mg/kg of thioacetamide, the antibody response to sheep red blood cells was significantly potentiated. In addition, the liver microsomal activities of CYP 2B enzymes were significantly induced by 1,8-cineole as in rats. Taken together, our results indicated that 1,8-cineole might be a useful CYP modulator in investigating the possible role of metabolic activation in chemical-induced hepatotoxicity and immunotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Antibody Formation / drug effects
  • Aspartate Aminotransferases / blood
  • Blotting, Western
  • Body Weight / drug effects
  • Carcinogens / toxicity*
  • Chemical and Drug Induced Liver Injury / enzymology
  • Chemical and Drug Induced Liver Injury / pathology*
  • Cyclohexanols / pharmacology*
  • Drug Synergism
  • Erythrocytes / immunology
  • Eucalyptol
  • Immunosuppressive Agents / toxicity*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Microsomes, Liver / metabolism
  • Mixed Function Oxygenases / metabolism
  • Monoterpenes / pharmacology*
  • Organ Size / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Sheep / immunology
  • Thioacetamide / toxicity*

Substances

  • Carcinogens
  • Cyclohexanols
  • Immunosuppressive Agents
  • Monoterpenes
  • Thioacetamide
  • Mixed Function Oxygenases
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Eucalyptol